Read + Share
Masuda Y, Kananazawa Y, Matsuno K, Kakinuma D, et al. Impact of Second-line Chemotherapy on Prognosis: Response of Advanced Gastric
Cancer to Taxanes Plus Ramucirumab. Anticancer Res 2022;42:1599-1605.
PMID: 35220257
|
 |
|
Masuda Y, Kananazawa Y, Matsuno K, Kakinuma D, et al. Impact of Second-line Chemotherapy on Prognosis: Response of Advanced Gastric
Cancer to Taxanes Plus Ramucirumab. Anticancer Res 2022;42:1599-1605.
PMID: 35220257
|
|
|
|